Brief: BB Biotech Q3 Profit Down At CHF 242 Mln
Oct 11 (Reuters) - BB Biotech AG BION.S :
* FOR NINE MONTHS PERIOD ENDED SEPTEMBER 30, 2018 A PROFIT OF CHF 172 MILLION VERSUS CHF 843
MILLION YEAR AGO
* IN Q3 A PROFIT OF CHF 242 MILLION (PROFIT OF CHF 365 MILLION IN CORRESPONDING PERIOD OF
PREVIOUS
YEAR)
Source text for Eikon: ID:nEQ4Nmjd9a
Further company coverage: BION.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM